New antigenic determinant (Sa) on human lymphocytes and phagocytes

Area of Science:

• Immunology
• Hematology
• Serology

Background:

• Cold agglutinins (CAs) are autoantibodies that agglutinate red blood cells at low temperatures.
• Understanding CA specificities is crucial for diagnosing and managing cold agglutinin disease.
• The existence of novel CA specificities requires thorough characterization.

Purpose of the Study:

• To investigate the presence and characteristics of a new cold agglutinin (CA) specificity, tentatively named Sa.
• To determine the reactivity and cytotoxic potential of CA Sa against various human blood cells.
• To differentiate the Sa specificity from previously identified cold agglutinin specificities.

Main Methods:

• Bithermic cytotoxicity assays were employed to assess the cell-killing activity of CA Sa.
• Immunofluorescence techniques were utilized to visualize the binding of CA Sa.
• Comparative analyses were performed against established cold agglutinin specificities (anti-I, anti-i).

Main Results:

• CA Sa demonstrated significant cytotoxicity against peripheral blood lymphocytes (PBL), particularly autologous PBL (up to 74%).
• A preferential killing of B-lymphocytes (B-PBL) over T-lymphocytes (T-PBL) was observed.
• CA Sa exhibited potent cytotoxicity against B-type chronic lymphocytic leukemia cells and susceptible thymocytes/T-helper cells, while sparing polymorphonuclear leukocytes.

Conclusions:

• The cold agglutinin Sa possesses a distinct specificity, differing from known CA specificities.
• CA Sa exhibits a unique cytotoxic profile, with notable activity against B-cells and specific T-cell subsets.
• These findings support the recognition of Sa as a new, previously undescribed cold agglutinin specificity.